LifeStance Health (LFST) Company Overview

LifeStance Health (LFST) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

TORONTO, Dec. 13, 2024 (GLOBE NEWSWIRE) -- Lifeist Wellness Inc. (“Lifeist” or the “Company”) (TSXV: LFST) (FRANKFURT: M5B0) (OTCMKTS: LFSWF), a health-tech company that leverages advancements in science and technology to support wellness in innovative ways, today announced a reorganization of its Board of Directors. As part of Lifeist's ongoing efforts to enhance corporate governance and further strengthen its leadership structure, Meni Morim, a director of the Company and the former CEO of the Company, has been appointed Chairman of the Board, while Branden Spikes, a director of the Company, has transitioned to the role of Lead Independent Director.

TORONTO, Dec. 09, 2024 (GLOBE NEWSWIRE) -- Lifeist Wellness Inc. (“Lifeist” or the “Company”) (TSXV: LFST) (FRANKFURT: M5B0) (OTCMKTS: LFSWF), a health-tech company that leverages advancements in science and technology to support wellness in innovative ways, is pleased to announce that its U.S. biosciences subsidiary Mikra Cellular Sciences Inc. ("Mikra") and a leader in science-driven health and wellness innovations, is launching a marketing initiative for the holiday season: The Mikra Wellness Giveaway. Mikra's latest campaign, designed to reward loyal customers and drive new customer acquisition, will run from today, December 9, 2024, to January 15, 2025, and include those purchases of Mikra's scientifically formulated supplements made on wearemikra.com.

TORONTO, Nov. 21, 2024 (GLOBE NEWSWIRE) -- Lifeist Wellness Inc. (“Lifeist” or the “Company”) (TSXV: LFST) (FRANKFURT: M5B0) (OTCMKTS: LFSWF), a health-tech company that leverages advancements in science and technology to support wellness in innovative ways, is pleased to announce the appointment of Andrea Judge as Chief Executive Officer of Lifeist Wellness Inc. effective today. Andrea, the current CEO of Lifeist's subsidiary Mikra Cellular Sciences Inc. (“Mikra”) since July 2024, will now lead Lifeist in its entirety.

New model for outpatient pediatric care combines seamlessly coordinated primary and specialty care with cutting-edge technology to transform the patient and family experience, and address physician burnout New model for outpatient pediatric care combines seamlessly coordinated primary and specialty care with cutting-edge technology to transform the patient and family experience, and address physician burnout

LifeStance Health Group, Inc. (NASDAQ:LFST ) Q3 2024 Earnings Conference Call November 7, 2024 8:30 AM ET Company Participants Monica Prokocki - Vice President of Investor Relations Ken Burdick - Chief Executive Officer Dave Bourdon - Chief Financial Officer Conference Call Participants Craig Hettenbach - Morgan Stanley Jack Senft - William Blair Jamie Perse - Goldman Sachs Stephanie Davis - Barclays Operator Thank you for standing by. My name is Liz and I'll be your conference operator today.

LifeStance Health Group (LFST) came out with a quarterly loss of $0.02 per share versus the Zacks Consensus Estimate of a loss of $0.07. This compares to loss of $0.17 per share a year ago.

SCOTTSDALE, Ariz., Nov. 07, 2024 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial results for the third quarter ended September 30, 2024.

Election stress is contributing to an increase in anxiety and strained relationships, reinforcing the importance of accessible mental healthcare  SCOTTSDALE, Ariz. , Oct. 8, 2024 /PRNewswire/ -- A LifeStance Health survey released today reveals how widespread election-related anxiety is impacting Americans' mental health, straining their personal relationships and prompting many to limit social media exposure.